EA200602129A1 - NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF DISKINESIA - Google Patents

NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF DISKINESIA

Info

Publication number
EA200602129A1
EA200602129A1 EA200602129A EA200602129A EA200602129A1 EA 200602129 A1 EA200602129 A1 EA 200602129A1 EA 200602129 A EA200602129 A EA 200602129A EA 200602129 A EA200602129 A EA 200602129A EA 200602129 A1 EA200602129 A1 EA 200602129A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
diskinesia
peptide compounds
new application
peptide
Prior art date
Application number
EA200602129A
Other languages
Russian (ru)
Inventor
Томас Штёр
Original Assignee
Шварц Фарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шварц Фарма Аг filed Critical Шварц Фарма Аг
Publication of EA200602129A1 publication Critical patent/EA200602129A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение направлено на применение класса пептидных соединений для лечения первичных или вторичных дискинезий, таких как лекарственная дискинезия.The present invention is directed to the use of a class of peptide compounds for the treatment of primary or secondary dyskinesias, such as drug dyskinesia.

EA200602129A 2004-05-18 2005-05-17 NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF DISKINESIA EA200602129A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57193204P 2004-05-18 2004-05-18
EP04011833A EP1604654A1 (en) 2004-05-18 2004-05-18 Novel use of peptide compounds for treating dyskinesia
PCT/EP2005/005355 WO2005110390A1 (en) 2004-05-18 2005-05-17 Novel use of peptide compounds for treating dyskinesia

Publications (1)

Publication Number Publication Date
EA200602129A1 true EA200602129A1 (en) 2007-04-27

Family

ID=34925049

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602129A EA200602129A1 (en) 2004-05-18 2005-05-17 NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF DISKINESIA

Country Status (12)

Country Link
US (1) US7416864B2 (en)
EP (2) EP1604654A1 (en)
JP (1) JP4938656B2 (en)
AT (1) ATE538781T1 (en)
AU (1) AU2005244440A1 (en)
BR (1) BRPI0511291A (en)
CA (1) CA2565051C (en)
EA (1) EA200602129A1 (en)
ES (1) ES2380510T3 (en)
MX (1) MXPA06013300A (en)
UA (1) UA86808C2 (en)
WO (1) WO2005110390A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE327744T1 (en) * 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh NEW USE OF PEPTIDE COMPOUNDS IN THE TREATMENT OF NON-NEUROPATHIC INFLAMMATORY PAIN
ATE228358T1 (en) * 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh NEW USE OF A CLASS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF ALLODYNIA OR OTHER TYPES OF CHRONIC OR PHANTOMATIC PAIN
KR20060111524A (en) * 2003-12-02 2006-10-27 쉬바르츠파르마에이지 Novel use of peptide compounds for treating central neuropathic pain
EP1579858A1 (en) * 2004-03-26 2005-09-28 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in painful diabetic neuropathy
US20100256179A1 (en) * 2004-03-26 2010-10-07 Ucb Pharma Gmbh Combination therapy for pain in painful diabetic neuropathy
US20070042969A1 (en) * 2004-03-26 2007-02-22 Srz Properties, Inc. Combination therapy for pain in painful diabetic neuropathy
NZ550482A (en) * 2004-04-16 2010-08-27 Sanol Arznei Schwarz Gmbh Use of peptidic compounds for the prophylaxis and treatment of chronic headache
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
EP1604655A1 (en) * 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
US7427601B2 (en) * 2004-06-24 2008-09-23 Schwarz Pharma Ag Method for treating tremor
BRPI0514721A (en) * 2004-08-27 2008-06-24 Sanol Arznei Schwarz Gmbh use of peptide compounds to treat bone cancer pain, chemotherapy-induced pain and nucleoside pain
EP1642889A1 (en) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
US20060252749A1 (en) * 2005-01-28 2006-11-09 Srz Properties, Inc. Lacosamide for add-on therapy of psychosis
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
US7902401B2 (en) * 2006-12-14 2011-03-08 Nps Pharmaceuticals, Inc. Fluorinated compounds
NZ567108A (en) * 2005-12-20 2011-10-28 Nps Pharma Inc Fluorinated compounds
KR101518427B1 (en) 2006-06-15 2015-05-08 유씨비 파르마 게엠베하 Pharmaceutical composition with synergistic anticonvulsant effect
EP1873527A1 (en) * 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
CN101466390B (en) 2006-06-15 2014-03-12 优时比制药有限公司 Pharmaceutical composition with synergistic anticonvulsant effect
WO2008070994A1 (en) * 2006-12-14 2008-06-19 Nps Pharmaceuticals, Inc. Use of d-serine derivatives for the treatment of anxiety disorders
WO2009053070A1 (en) 2007-10-23 2009-04-30 Schwarz Pharma Ag Compounds for treating demyelination conditions
CA2774569A1 (en) 2009-09-23 2011-03-31 The University Of North Carolina At Chapel Hill Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
EP2645997B1 (en) 2010-12-02 2022-08-10 UCB Pharma GmbH Once daily formulation of lacosamide
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU84891A1 (en) * 1983-06-30 1985-03-29 Continental Pharma 2-AMINOACETIC ACID DERIVATIVES, THEIR PREPARATION AND USE AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES
US5378729A (en) 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
DK0461958T3 (en) * 1990-06-15 1995-02-20 Synthelabo 2- (aminoalkyl) -5- (arylalkyl) -1,3-dioxane derivatives, process for their preparation and use in therapy
US5773475A (en) * 1997-03-17 1998-06-30 Research Corporation Technologies, Inc. Anticonvulsant enantiomeric amino acid derivatives
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
US5866585A (en) * 1997-05-22 1999-02-02 Synchroneuron, Llc Methods of treating tardive dyskinesia using NMDA receptor antagonists
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
ATE375793T1 (en) * 2000-08-25 2007-11-15 Res Corp Technologies Inc USES OF ANTICONVULSIVE AMINO ACID FOR TREATING BIPOLAR DISEASES
ATE327744T1 (en) * 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh NEW USE OF PEPTIDE COMPOUNDS IN THE TREATMENT OF NON-NEUROPATHIC INFLAMMATORY PAIN
ATE228358T1 (en) * 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh NEW USE OF A CLASS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF ALLODYNIA OR OTHER TYPES OF CHRONIC OR PHANTOMATIC PAIN

Also Published As

Publication number Publication date
UA86808C2 (en) 2009-05-25
JP2007538037A (en) 2007-12-27
US7416864B2 (en) 2008-08-26
ATE538781T1 (en) 2012-01-15
ES2380510T3 (en) 2012-05-14
US20050261204A1 (en) 2005-11-24
EP1604654A1 (en) 2005-12-14
CA2565051A1 (en) 2005-11-24
EP1753414B1 (en) 2011-12-28
JP4938656B2 (en) 2012-05-23
BRPI0511291A (en) 2007-12-04
EP1753414A1 (en) 2007-02-21
WO2005110390A1 (en) 2005-11-24
CA2565051C (en) 2013-01-22
AU2005244440A1 (en) 2005-11-24
MXPA06013300A (en) 2007-02-22

Similar Documents

Publication Publication Date Title
EA200602129A1 (en) NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF DISKINESIA
EA201170441A1 (en) THERAPEUTIC ANTI-VIRAL PEPTIDES
EA200700225A1 (en) TETRAPTIDE ANALOGUES
EA201070247A1 (en) PROTEAS INHIBITORS
EA201001847A1 (en) COMPOUNDS AND COMPOSITIONS APPLICABLE FOR THE TREATMENT OF MALARIA
NO20081636L (en) FAP inhibitors
EA200900959A1 (en) MEK INHIBITORS
BRPI0510177B8 (en) compound, pharmaceutical composition and use thereof
NO20074238L (en) Fixed dosage of HER antibodies
EA201170872A1 (en) PROTEINKINASE INHIBITORS
EA201100037A1 (en) ORGANIC COMPOUNDS
EA200601912A1 (en) APPLICATION OF PEPTIDE COMPOUNDS FOR PREVENTION AND TREATMENT OF CHRONIC HEADACHE
NO20072092L (en) sulfonamide
RS54123B1 (en) Therapeutic combination comprising dolutegravir, abacavir and lamivudine
MX2008007808A (en) Rifamycin analogs and uses thereof.
EA200971068A1 (en) TRIAZOLYLAMINOPYRIMIDINE COMPOUNDS
EA201691759A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF PULMONARY HYPERTENSION
EA200801199A1 (en) KINASE INHIBITORS
CL2007002384A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis.
EA201190125A1 (en) TABLETS FOR COMBINED THERAPY
EA201290416A1 (en) NEW SPYROPYPERIDINE CONNECTIONS
EA200700702A1 (en) LOKSAPINA ANALOGUES AND METHODS OF THEIR APPLICATION
EA200970126A1 (en) METHOD OF OBTAINING PREGABALIN AND ITS ENANTIOMER
ATE417849T1 (en) PYRAZOLOA4,3-DÜPYRIMIDINE
CL2007002388A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of hemangiomas or hemangioblastomas.